Profil
Richard T.
Kenney is currently President at ClinReg Biologics LLC since 2016.
Also holds memberships at the American Federation for Medical Research and the American Society of Tropical Medicine & Hygiene.
Formerly Senior Director-Global Clinical at ID Biomedical Corp.
(2009), Vice President-Clinical Development at Vical, Inc. (2010-2012), Chief Medical Officer at Marker Therapeutics, Inc., Vice President-Medical & Regulatory Affairs at Valneva Usa, Inc. (2005), Chief Medical Officer at Janssen Vaccines & Prevention BV (2012-2013), Principal at US Food & Drug Administration, Chief Medical Officer at Immune Design Corp.
(2013-2016), Chief Development Officer at X-Vax Technology, Inc. (2017-2021), and Chief Medical Officer at Sonnet BioTherapeutics Holdings, Inc. (2021-2025).
Education includes undergraduate degree from George Washington University and doctorate from Harvard Medical School.
Aktive Positionen von Richard Kenney
| Unternehmen | Position | Beginn |
|---|---|---|
American Federation for Medical Research
American Federation for Medical Research Miscellaneous Commercial ServicesCommercial Services Operates as a nonprofit organization that supports clinical and translational researchers through meetings, education & professional development programs | Corporate Officer/Principal | - |
American Society of Tropical Medicine & Hygiene
American Society of Tropical Medicine & Hygiene Miscellaneous Commercial ServicesCommercial Services Engages in promoting global health through the prevention and control of diseases affecting the poor | Corporate Officer/Principal | - |
ClinReg Biologics LLC
ClinReg Biologics LLC Pharmaceuticals: MajorHealth Technology ClinReg Biologics LLC is a specialized consulting firm that offers guidance in biologic drug development, including strategic development planning, due diligence, clinical trial design, medical monitoring, pharmacovigilance, and product failure investigation. The private company is based in Maryland. The American company focuses on biologics related to vaccines, infectious diseases, oncology, immunotherapy, molecular parasitology, and cellular immunology, providing consulting solutions for translational-stage development in public health and commercial sectors. | Präsident | 01.09.2016 |
Ehemalige bekannte Positionen von Richard Kenney
| Unternehmen | Position | Ende |
|---|---|---|
| SONNET BIOTHERAPEUTICS | Technik-/Wissenschafts-/F&E-Leiter | 02.12.2025 |
X-Vax Technology, Inc.
X-Vax Technology, Inc. BiotechnologyHealth Technology Develops biotechnology products | Corporate Officer/Principal | 01.02.2021 |
| IMMUNE DESIGN CORP | Technik-/Wissenschafts-/F&E-Leiter | 16.06.2016 |
Janssen Vaccines & Prevention BV
Janssen Vaccines & Prevention BV Pharmaceuticals: MajorHealth Technology Manufactures and supplies biopharmaceutical products | Technik-/Wissenschafts-/F&E-Leiter | 01.08.2013 |
Vical, Inc.
Vical, Inc. Pharmaceuticals: MajorHealth Technology Develops biopharmaceutical products | Technik-/Wissenschafts-/F&E-Leiter | - |
Ausbildung von Richard Kenney
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 14 |
|---|---|
Vical, Inc.
Vical, Inc. Pharmaceuticals: MajorHealth Technology Develops biopharmaceutical products | Health Technology |
ID Biomedical Corp.
ID Biomedical Corp. Medical SpecialtiesHealth Technology Develops gene-based disease testing and subunit vaccines | Health Technology |
Marker Therapeutics, Inc.
Marker Therapeutics, Inc. BiotechnologyHealth Technology Develops and commercializes cell based immune therapeutics and vaccines for cancer treatment | Health Technology |
George Washington University
George Washington University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Intercell USA, Inc.
Intercell USA, Inc. BiotechnologyHealth Technology Discovers and develops vaccines and immune system stimulants | Health Technology |
Janssen Vaccines & Prevention BV
Janssen Vaccines & Prevention BV Pharmaceuticals: MajorHealth Technology Manufactures and supplies biopharmaceutical products | Health Technology |
US Food & Drug Administration
US Food & Drug Administration General GovernmentGovernment Operates agencies to protect health and human services | Government |
American Federation for Medical Research
American Federation for Medical Research Miscellaneous Commercial ServicesCommercial Services Operates as a nonprofit organization that supports clinical and translational researchers through meetings, education & professional development programs | Commercial Services |
American Society of Tropical Medicine & Hygiene
American Society of Tropical Medicine & Hygiene Miscellaneous Commercial ServicesCommercial Services Engages in promoting global health through the prevention and control of diseases affecting the poor | Commercial Services |
Immune Design Corp.
Immune Design Corp. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical and clinical-stage immunotherapy company | Health Technology |
Harvard Medical School
Harvard Medical School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
X-Vax Technology, Inc.
X-Vax Technology, Inc. BiotechnologyHealth Technology Develops biotechnology products | Health Technology |
ClinReg Biologics LLC
ClinReg Biologics LLC Pharmaceuticals: MajorHealth Technology ClinReg Biologics LLC is a specialized consulting firm that offers guidance in biologic drug development, including strategic development planning, due diligence, clinical trial design, medical monitoring, pharmacovigilance, and product failure investigation. The private company is based in Maryland. The American company focuses on biologics related to vaccines, infectious diseases, oncology, immunotherapy, molecular parasitology, and cellular immunology, providing consulting solutions for translational-stage development in public health and commercial sectors. | Health Technology |
Sonnet BioTherapeutics Holdings, Inc.
Sonnet BioTherapeutics Holdings, Inc. BiotechnologyHealth Technology Develops immuno-oncology therapeutics | Health Technology |
















